This article describes how CDC designed and produced two de-identified datasets for public use from person-level, de-identified data collected by the CDC from jurisdictions from more than 8 million records.
Protecting Privacy and Transforming COVID-19 Case Surveillance Datasets for Public Use
Related Topics
Disease Tracking and Surveillance
Disease surveillance helps us detect disease cases, understand burden of disease and risk factors, provide the basis for timely and informed decision-making, guide control measures, and monitor impacts. Since the onset of COVID-19, surveillance efforts have worked to provide real-time tracking and forecast data, despite challenges with diagnostic capacity, case reporting, insufficient contact tracing, and fragmented data systems. COVID-19 has highlighted the need to invest in modern data systems, expand and skill up the workforce, and ensure data reporting and interpretation retain high ethical and epidemiological standards.